Novo Nordisk is a world leader in diabetes treatment
(Image credit: Novo Nordisk)
The last few months have been a disappointment for the end-of-the-world crowd. Some Remainers may be dismayed by the stability of sterling and the acceleration of economic growth in the UK to 0.5% in the first quarter. Brexiters are disappointed by the pick-up in European growth to 0.4%, with unemployment at a ten-year low and even Italy out of recession. Meanwhile, the recovery in equity markets this year suggests that investors are losing interest in politics and focusing on corporate factors instead.
However, there is a long way to go. Sam Morse, the manager of the £1bn Fidelity European Values (LSE: FEV) trust since 2010, points to strong residual negative sentiment towards Europe. Fund flows into EU equities are near 15-year lows, and fund-manager surveys show that investment intentions are at six-year lows. Earnings growth in Europe has lagged the US, but valuations are significantly lower. At the end of March, the US market was valued at 17.2 times 2019 forecast earnings, and the eurozone at 13.2. If economic growth and growth in profits is picking up, European markets could at last outperform the US.
FEV, once run by respected fund manager Anthony Bolton, has an enviable record. It launched in 1991 and has returned a compound annual average of 13.8%, compared with 9.1% for the FTSE Europe index, enough to multiply an initial investment 35-fold. The three- and five-year performances, 53% and 68% (respectively 12% and 22% ahead of the index), are among the best in its sector. The dividend yield is 2.8%, yet the shares trade on a discount to net asset value of 9%. The annual outperformance may have decelerated to 2.8%, but these are still exceptional returns at a great price.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Fidelity's research shows significant outperformance by companies that consistently grow their dividends over those that cut or just maintain them. The FEV portfolio "yields between 75% and 95% of the market, but with faster growth". A long-term view is shown by portfolio turnover barely above 15% per year, which means that stocks are held on average for six years, and 60% of holdings were held five years ago. Protection against downside is demonstrated by a strong tendency to outperform in down months; in 2018, for example, the trust lost only 4.8%, while the market was down 9.5%.
The portfolio includes consumer stocks such as Nestl, LVMH and L'Oral, healthcare stocks such as Roche, Sanofi and Novo Nordisk (the world leader in diabetes treatment), and financial stocks such as Deutsche Brse and DNB (the leading Norwegian bank), but not the lame-duck German banks. There are no car companies or retailers, no recovery stocks, and none that look suspiciously cheap.
For most of the trust's life, European markets outperformed the world, and have only lagged in the last ten years. Morse won't be drawn as to when outperformance will return, but notes that the dollar is "10%-15% overvalued against the euro" and that "Europe is very out of fashion". The EU may have its structural problems, but the opportunities for profit will at least continue. Don't let politics get in the way of a good investment.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
Annual house price growth halves to 3.5% – ONS
Nationwide pays £100 to millions of people – have you received the payment?
